Homepage
More Important Than Free Lab Space: Golden Ticket Opens the Door to Work With the Cystic Fibrosis Foundation
“Winning the Golden Ticket has had a major impact on Nosis Bio,” says Chad Miller, principal scientist and a co-founder of the company. “More important than the free lab space, the Golden Ticket opened the door to the Foundation, which has an incredible track record of supporting biotech companies to develop revolutionary therapeutics.” Read post
The AI Effect: How a Hot Computing Tool Is Tying ‘Bio’ and ‘Tech’ Closer Than Ever
“In protein design, until the last couple of years, successes were rare,” said Fraser, a professor of bioengineering and therapeutic sciences in UCSF’s School of Pharmacy. “(AI has) just been a sea change. Stuff works now.” Those successes are elevating a new generation of AI-focused drug-development companies in the Bay Area, including Profluent Bio, a 20-person Berkeley startup founded by the leaders of the Salesforce project. In the wake created by ChatGPT and a wealth of biological data, those companies may be key to AI’s evolving ability to fix human ills. Read post
Startup Launches With ‘RNA Sensor’ Technology From Stanford and MIT To Better Control mRNA Therapies
“We want to turn off an RNA transcript and prevent it from being expressed by default,” CSO Eerik Kaseniit, a former graduate student who worked on the technology in Gao’s lab, told Endpoints News in an interview. Radar’s scientists do that by adding a stop codon — three genetic letters that are the molecular equivalent of a red light — in front of the mRNA therapy, which prevents cells from reading the message. Read post
Jim Collins’ Latest Venture Raises $13.4M To Programme Logic-Gated mRNA Therapies
Radar Therapeutics thinks it can push the technology to the next level – and into more diseases – with safety switches that boost cell specificity, safety, and accessibility. The biotech, co-founded by MIT professor and synthetic biology pioneer Jim Collins, launched Thursday with a $13.4-million seed round led by NfX Bio and boasting Eli Lilly as one of its investors. Read post
Radar Therapeutics Raises $13 Million to Design Therapies Using RNA Sensors
Radar Therapeutics emerged from stealth this week with an announcement that it had raised $13.4 million in an oversubscribed seed financing round led by NfX Bio. Eli Lilly & Co, Biovision, and KdT Ventures also joined the round, with participation from PearVC, BEVC, and other investors. They will use the funds to advance various internal programs, expand their team, and pursue partnership opportunities. Read post Bakar ClimatEnginuity Hub: Berkeley’s New Home for Climate Innovation
A new incubator on the west side of campus will provide resources and support to entrepreneurs in renewable energy and clean technology. Read post
Stopping Acute Bleeds, Starting With Severe Postpartum Hemorrhage
Coagulant Therapeutics is developing a novel pipeline of therapeutics to treat acute bleeds led by CT-001, a next-generation factor VIIa (FVIIa) molecule. Read postOur affiliates
Ready to run?
Startups need to focus on making milestones, not managing equipment.
Bakar Labs maintains tissue culture facilities, a freezer farm, fume hoods, basic benchtop equipment and plenty of analytical instruments. Optional lab support services can also make for quick starts that help get results fast.
At UC Berkeley
Bakar Labs is just steps from UC Berkeley’s world-renowned faculty and more than 40,000 students who train in top programs including science, engineering, law and business. Dotting the campus is a network of core facilities that feature a wide range of advanced equipment and services for use by startups. Recruiting student talent and scientific co-founders couldn’t be easier.
Today’s best startups blaze a trail all their own, but they don’t do it alone.
They build their support network to help them navigate the multiple challenges they face. At Bakar Labs, tenants join a community of as many as 50 like-minded teams willing to share the scientific and business insights that help them advance. The incubator spans more than 40,000 square feet of lab and office spaces within the fully renovated Woo Hon Fai Hall, the iconic former home of the Berkeley Art Museum. With so much going on, investors, industry partners and new talent are already taking notice.
Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.
